Cargando…

Heart failure ejection fraction class conversions: impact of biomarkers, co‐morbidities, and pharmacotherapy

AIMS: Temporal conversions among ejection fraction (EF) classes can occur across the heart failure (HF) spectrum reflecting amended structural and functional outcomes unaccounted for by current taxonomy. This retrospective study aims to investigate the differences in serum laboratory values, guideli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorenzo, Christian J., Conte, Jorge I., Villasmil, Ricardo J., Abdelal, Qassem K., Pierce, Derek, Wiese‐Rometsch, Wilhelmine, Garcia‐Fernandez, Joel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288751/ https://www.ncbi.nlm.nih.gov/pubmed/35570322 http://dx.doi.org/10.1002/ehf2.13965

Ejemplares similares

Hypersecretory Paraganglioma Presenting as Acute Aortic Dissection
por: Lorenzo, Christian J., et al.
Publicado: (2020)

SAT-593 Thyrotoxic Heart Disease: Rare but Serious Manifestation of Congestive Heart Failure
por: Petrenko, Olesya, et al.
Publicado: (2019)

A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge
por: Bell, Stephen, et al.
Publicado: (2021)

REMDESIVIR PLUS DEXAMETHASONE VS TOCILIZUMAB OR BARICITINIB SUPPLEMENTATION INITIATED INSIDE 48 HOURS OF INDEX COVID-19 HOSPITALIZATION IN ICU PATIENTS
por: WILLIAMS, STEPHANIE N, et al.
Publicado: (2022)

Using Objective Electrocardiographic Data To Better Predict Mortality In Patients Hospitalized With COVID-19
por: Malik, Bobby, et al.
Publicado: (2023)

Presentation Traits Of Vaccinated Versus Unvaccinated Heart Failure Patients At Acute Covid-19 Hospitalization
por: Burns, Katherine, et al.
Publicado: (2023)

Idiopathic Granulomatous Mastitis Presenting in a Patient With Hypothyroidism and Recent Hospitalization for Myxedema Coma: A Rare Case Report and Review of Literature
por: Bell, Stephen, et al.
Publicado: (2020)

Alpelisib-Induced Diabetic Ketoacidosis- A Case Report
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021)

Updates in pharmacotherapy of heart failure with reduced ejection fraction
por: Espinoza, Clifton, et al.
Publicado: (2021)

A case report of disseminated herpes simplex hepatitis masquerading as spinal headache
por: Lattanzio, Natalia, et al.
Publicado: (2020)

Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
por: Idogun, Precious O, et al.
Publicado: (2021)

PERSONALIZED BASELINE RISK STRATIFICATION IN HOSPITALIZED ADULT PATIENTS WITH COVID-19: PATIENT-SIMILARITY-BASED DATA SCIENCE SHEDS SOME LIGHT
por: LATTANZIO, NATALIA, et al.
Publicado: (2021)

Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction
por: Paz, Pablo Alejandro, et al.
Publicado: (2021)

Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
por: Benko, Jakub, et al.
Publicado: (2022)

SUN-422 Panhypopituitarism Secondary to Pituitary Macroadenoma with Optic Chiasm Compression and Possible Apoplexy
por: Petrenko, Olesya, et al.
Publicado: (2019)

Complete Blood Count Parameters Outperform Putative Inflammatory Markers in Predicting COVID-19 Mortality: A Multimodal Machine Learning Model
por: Idogun, Precious, et al.
Publicado: (2021)

In-Hospital Glycemic Dysregulation Associated With Worse Outcomes in COVID-19
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021)

Effectiveness of COVID-19 Convalescent Plasma Infusion Within 48 Hours of Hospitalization With SARS-CoV-2 Infection
por: Lattanzio, Natalia, et al.
Publicado: (2021)

Sa1428: SARS-COV-2 INFECTION EVOKED HYPOALBUMINEMIA PREDICTS PROGRESSION TO CRITICAL ILLNESS IN PATIENTS WITH MILD TO SEVERE LIVER DISEASE
por: Nora, Ian, et al.
Publicado: (2022)

COMPARATIVE EFFECTIVENESS OF INHALED NITRIC OXIDE IN ARDS AND VIRAL PNEUMONIA WITH AND WITHOUT COVID-19
por: JR, RICHARD WALO, et al.
Publicado: (2022)

Acinetobacter radioresistens and Enterococcus casseliflavus co-infection with endocarditis, bacteremia, and pneumonia
por: Motie, Ian, et al.
Publicado: (2022)

Pharmacotherapies in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Baral, Nischit, et al.
Publicado: (2021)

Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction
por: Wongsalap, Yuttana, et al.
Publicado: (2023)

Mycobacterium fortuitum ventriculoperitoneal shunt infection in an immunocompromised patient: A case report
por: Lattanzio, Natalia, et al.
Publicado: (2020)

1367. COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalizations Across the Four SARS-CoV-2 Pandemic Waves in Florida
por: Motie, Ian, et al.
Publicado: (2023)

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
por: Santas, Enrique, et al.
Publicado: (2020)

Supervised Analysis for Phenotype Identification: The Case of Heart Failure Ejection Fraction Class
por: Lopez, Cristina, et al.
Publicado: (2021)

Right ventricular ejection fraction in postoperative cardiac surgery patients is independently associated with ICU morbidity and mortality
por: Bootsma, IT, et al.
Publicado: (2015)

THU331 Glycemic Variability In Critically Ill Sepsis Patients Comorbid With COVID-19: Relative Impact Of Diabetes And/Or Obesity
por: June Rebernigg, Janevi, et al.
Publicado: (2023)

Relative contribution of risk factors/co‐morbidities to heart failure pathogenesis: interaction with ejection fraction
por: Giamouzis, Grigorios, et al.
Publicado: (2020)

Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction
por: Cao, Yalin, et al.
Publicado: (2023)

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes
por: Tschöpe, Diethelm, et al.
Publicado: (2013)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

THU332 Composite Glucose And Albumin Biomarker Tool Provides Strong Mortality Risk Assessment At Presentation And Throughout Index COVID-19 Hospitalization
por: Torres Rivera, Nicole, et al.
Publicado: (2023)

Diabetes Associated With Greater Ejection Fraction Improvement After Revascularization in Patients With Reduced Ejection Fraction
por: Wang, Shaoping, et al.
Publicado: (2021)

Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2011)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6uckn5mbtml75iaql7efrud6lc